Myriad Genetics INC Form 4 insider transactions

NASDAQ
Chief Financial Officer Scott J. Leffler of Myriad Genetics reported the acquisition of restricted stock units and the disposal of common stock on March 14, 2024.
NASDAQ
Paul Diaz, President and CEO of Myriad Genetics, reports acquisition of stock units and disposition of shares to cover tax obligations.
NASDAQ
Chief People Officer Shereen Solaiman of Myriad Genetics reports the withholding of shares to cover tax obligations related to vested restricted stock units.